USPTO 2015–2025 USPTO PatentsView US Corporation

Bard Peripheral Vascular, Inc.

USPTO PatentsView assignee record — 114 granted patents across 26 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

114
Total patents granted
26
CPC technology areas
15.6
Avg claims per patent
+48%
5-year filing velocity

Portfolio overview

Bard Peripheral Vascular, Inc. has been granted 114 US utility patents between 2015 and 2025, placing Bard Peripheral Vascular, Inc. at rank #3,273 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Bard Peripheral Vascular, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 51.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 68 grants, compared with 46 in the 2015–2019 window — a +48% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Bard Peripheral Vascular, Inc.'s 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bard Peripheral Vascular, Inc. against peers pursuing similar technology classes.

How does Bard compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Bard holds 114 patents — placing it at rank #3,273 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

5101520 20152016201720182019202020212022202320242025 14
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Bard Peripheral Vascular, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 8 7.0%
2016 9 7.9%
2017 6 5.3%
2018 9 7.9%
2019 14 12.3%
2020 11 9.6%
2021 7 6.1%
2022 8 7.0%
2023 11 9.6%
2024 17 14.9%
2025 14 12.3%

Which technologies does Bard Peripheral Vascular, Inc. patent most?

Top 15 of 26 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#3,273

Across all tracked assignees

Innovation Score

51.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Bard Peripheral Vascular, Inc. hold?
Bard Peripheral Vascular, Inc. holds 114 US granted patents filed between 2015 and 2025, spanning 26 technology areas.
What is Bard Peripheral Vascular, Inc.'s Innovation Score?
Bard Peripheral Vascular, Inc. has an Innovation Score of 51.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Bard Peripheral Vascular, Inc. focus on?
Bard Peripheral Vascular, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 71 patents. The company has filed patents in 26 CPC subclasses total.
Is Bard Peripheral Vascular, Inc.'s patent filing rate increasing or decreasing?
Bard Peripheral Vascular, Inc.'s recent filing velocity is +48% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Bard Peripheral Vascular, Inc.'s patents?
Bard Peripheral Vascular, Inc.'s patents average 15.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Bard Peripheral Vascular, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope